Bergoz R
Schweiz Med Wochenschr. 1985 Jul 20;115(29):1024-5.
In an open study, 40 patients with duodenal ulcer of several years' standing were treated for relapse with either TDB (De-Nol) or cimetidine. No difference in the relapse rate was observed during the subsequent 12 months. Analysis of the data in relation to smoking habits did, however, reveal an advantage (p less than 0.05) for non-smokers during the first 6 months.
在一项开放性研究中,40例患有多年十二指肠溃疡的患者因复发接受了替普瑞酮(得乐)或西咪替丁治疗。在随后的12个月中,未观察到复发率有差异。然而,根据吸烟习惯对数据进行分析时发现,在前6个月中,不吸烟者具有优势(p<0.05)。